SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
XBIT

XBiotech Inc. (NASDAQ:XBIT)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.94-0.05 (-2.51%)
 
Market cap
$59.1M
Insider Score
Health Score
Analyst consensus
Listed since
Apr 15, 2015
Market Cap59.15M-18.1%
Revenue (ttm)0
Net Income-45.13M-60.3%
EPS-1.48-61.3%
Shares Out30.49M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend DateJul 15, 2021
Volume73,090
Open1.98
Previous Close1.99
Day's Range1.87 - 1.98
52-Week Range1.80 - 3.44
Beta0.80
AnalystsBuy
Price Targetn/a
Earnings Daten/a
-2.51% (1D)
No price history available.
Insider Score
/ 99
XBIT Insider Score

XBiotech Inc. has a live Insider Score.

Scored on 1 qualifying trade from 1 insider in the last 90 days.

Unlock XBIT’s Insider Score

XBiotech Inc. Stock Analysis — InsiderScore

See top-rated InsiderScore stocks ›
XBIT InsiderScore:

The InsiderScore for XBiotech Inc. is members only. Insider Access opens the score, its star rating, and how XBIT ranks against every other company we score. The categories below, and what each one found, are free to read.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Unlock XBIT’s InsiderScore
Dollars Committed

Insiders at XBiotech Inc. bought $711.3K of stock across 1 purchase in the last 90 days, the largest of them $711.3K.

Stake Increase

The average purchase added about 10% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

Every buyer already held stock, so each purchase is an increase rather than a first position.

This category carries 35% of the Insider Score.

About XBIT

XBiotech Inc. is a biopharmaceutical firm specializing in the discovery, development, and commercialization of True Human monoclonal antibodies. Their primary focus involves building a robust pipeline of product candidates aimed at combating both inflammatory and infectious diseases. Furthermore, the company is advancing interleukin-1 alpha-based therapies, which are designed to address a broad spectrum of medical conditions such as cancer, stroke, heart attack, and arthritis. Interleukin-1 alpha itself plays a crucial role in biological processes like tissue breakdown, angiogenesis, blood clot formation, malaise, muscle wasting, and inflammation. Additionally, XBiotech is developing a True Human COVID-19 therapy specifically targeting mutant strains of the virus. Established in 2005, XBiotech Inc. maintains its headquarters in Austin, Texas.

Address
5217 Winnebago Lane, Austin, TX, 78744, US
Market Cap
59 million
Employees
87
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$711.25K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Sound
From XBIT’s reported statements · Q2 2026 (trailing 12 months) · 4 of 5 pillars

Ask Barron about XBIT

1 Day
-2.51%
5 Days
-0.51%
1 Month
-11.01%
6 Months
-23.02%
1 Year
-18.14%

$XBIT stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in XBIT holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by XBIT's directors and management

Net Shares Purchased by Insiders−400k−200k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

XBIT Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New XBIT patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to XBIT from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in XBIT

ETFEst. Holding Size
VXFVanguard Extended Market ETF$438.40K
IWCiShares Micro-Cap ETF$141.99K
BSVOEA Bridgeway Omni Small-Cap Value ETF$120.00K
SILXETFMG Prime 2x Daily Junior Silver Miners ETF$53.47K
VALTETFMG Sit Ultra Short ETF$49.34K
GERMETFMG Treatments, Testing and Advancements ETF$44.51K

Estimated from each fund’s disclosed top holdings × AUM

XBIT Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

Members only

The live Insider Score for XBIT is included with Insider Access.

Unlock Insider Score

Bull Case vs Bear Case

AI-generated from XBIT’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

Members only

The live Insider Score and its full factor breakdown are included with Insider Access.

Unlock Insider Score

Recent Insider Activity

Buys
1
Sells
0
Buy Value
$711.25K
Distinct Buyers
1

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.